Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > Apart from traveling

<< Previous

Bullboard Posts

Next >>

Comment by francoisl13on Jun 13, 2024 12:56pm

64 Views

Post# 36087423

RE:RE:RE:Apart from traveling

100% agree with your comment about KNE typically not meeting deadlines...deadlines that they are setting themself...I think that they should be using a more conservative approach when mentioning deadlines, that way they will not disappoint the investment community and, their own shareholders.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec